EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia

Darmiga Thayabaran, Anson P T Tsui, Stefan Ebmeier, Jaimini Cegla, Alessia David, Ben Jones

Journal of Clinical Lipidology · 2023-03 · 17 (2) · 244-254

DOI: 10.1016/j.jacl.2023.01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2023-03. Verfasst von Darmiga Thayabaran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College Healthcare NHS Trust, London, UK (Drs Thayabaran, Cegla, David and Jones). Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Familial hypercholesterolaemia (FH) diagnostic tools help prioritise patients for genetic testing and include LDL-C estimates commonly calculated using the Friedewald equation. However, cholesterol contributions from lipoprotein(a) (Lp(a)) can overestimate 'true' LDL-C, leading to potentially inappropriate clinical FH diagnosis. OBJECTIVE: To assess how adjusting LDL-C for Lp(a)-cholesterol affects FH diagnoses using Simon Broome (SB) and Dutch Lipid Clinic Network (DLCN) criteria. METHODS: Adults referred to a tertiary lipid clinic in London, UK were included if they had undergone FH genetic testing based on SB or DLCN criteria. LDL-C was adjusted for Lp(a)-cholesterol using estimated cholesterol contents of 17.3%, 30% and 45%, and the effects of these adjustments on reclassification to 'unlikely' FH and diagnostic accuracy were determined. RESULTS: Depending on the estimated cholesterol content applied, LDL-C adjustment reclassified 8-23% and 6-17% of patients to 'unlikely' FH using SB and DLCN criteria, respectively. The highest reclassification rates were observed following 45% adjustment in mutation-negative patients with higher Lp(a) levels. This led to an improvement in diagnostic accuracy (46% to 57% with SB, and 32% to 44% with DLCN following 45% adjustment) through increased specificity. However all adjustment factors led to erroneous reclassification of mutation-positive patients to 'unlikely' FH. CONCLUSION: LDL-C adjustment for Lp(a)-cholesterol improves the accuracy of clinical FH diagnostic tools. Adopting this approach would reduce unnecessary genetic testing but also incorrectly reclassify mutation-positive patients. Health economic analysis is needed to balance the risks of over- and under-diagnosis before LDL-C adjustments for Lp(a) can be recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIAdultHumansCholesterol, LDLGenetic TestingMutationLipoprotein(a)

Stichwörter der Autor:innen

Dutch Lipid Clinic Network criteriaFamilial hypercholesterolaemiaLDL-cholesterolLipoprotein(a)Simon Broome criteria

Substanzen

Cholesterol, LDLLipoprotein(a)

Autor:innen und Institutionen

  • Imperial College Healthcare NHS Trust, London, UK (Drs Thayabaran, Cegla, David and Jones).
  • Imperial College London, London, UK (Mr Tsui).
  • Department of Infectious Diseases, Imperial College London, London, UK (Dr Ebmeier).
  • Imperial College Healthcare NHS Trust, London, UK (Drs Thayabaran, Cegla, David and Jones); Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK (Drs Cegla and Jones).
  • Imperial College Healthcare NHS Trust, London, UK (Drs Thayabaran, Cegla, David and Jones); Department of Life Sciences, Imperial College London, London, UK (Dr David).
  • Imperial College Healthcare NHS Trust, London, UK (Drs Thayabaran, Cegla, David and Jones); Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK (Drs Cegla and Jones). Electronic add…

Förderung

  • Medical Research Council

Zitieren

APA

Thayabaran, D., Tsui, A. P. T., Ebmeier, S., Cegla, J., David, A., & Jones, B. (2023). The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia. Journal of Clinical Lipidology, 17(2), 244-254. https://doi.org/10.1016/j.jacl.2023.01.006

Vancouver

Thayabaran D, Tsui APT, Ebmeier S, Cegla J, David A, Jones B. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia. Journal of Clinical Lipidology. 2023;17(2):244-254. doi:10.1016/j.jacl.2023.01.006

BibTeX
@article{Thayabaran2023,
  author = {Thayabaran, Darmiga and Tsui, Anson P T and Ebmeier, Stefan and Cegla, Jaimini and David, Alessia and Jones, Ben},
  title = {The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia},
  journal = {Journal of Clinical Lipidology},
  year = {2023},
  volume = {17},
  number = {2},
  pages = {244--254},
  doi = {10.1016/j.jacl.2023.01.006}
}
Kostenlos starten →